Category:

MyoKardia Appoints Denelle J. Waynick as General Counsel and Corporate Secretary

MyoKardia, Inc. a clinical-stage biopharmaceutical company announced that Denelle Waynick has been appointed as the new General Counsel and Corporate Secretary. Ms. Waynick worked in UCB, Inc., and has more than 25 years of domestic and international legal and business expertise in the healthcare and life-science industry. Ms. Waynick most recently worked in UCB as Continue Reading

Posted On :